CNBX - CNBX files patent application for cancer treatment with cannabinoids in US and Israel

• CNBX Pharmaceuticals ( OTCQB:CNBX ) said on Thursday it had filed a patent application titled composition and method for treating cancer with cannabinoids with the US Patent and Trademark Office and Israel Patent Office.
• The company said the patent application relates to several of the drug candidates on the its pipeline for the treatment of various types of cancer, including CNBX RCC-33, for the treatment of colorectal cancer currently being developed and prepared for a pre-IND meeting with the FDA.

For further details see: